Exploration of vitamin D metabolic activity-related biological effects and corresponding therapeutic targets in prostate cancer.

Background: Previous studies have unequivocally demonstrated that the vitamin D (VD) metabolism pathway significantly influences prognosis and sensitivity to hormone therapy in prostate cancer (PCa). However, the precise underlying mechanism remains unclear. Methods: We performed molecular profiling...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Metabolism Vol. 21; no. 1; pp. 1 - 18
Autores principales: Ding, Lei, Wang, Yong, Tang, Zhentao, Ni, Chenbo, Zhang, Qian, Zhai, Qidi, Liang, Chao, Li, Jie
Formato: pictorial research tables/charts Journal Article
Publicado: BioMed Central 4/2/2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176405915&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 176405915
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17437075
        1CYX
      jtl: Nutrition & Metabolism
      issn: 17437075
      maglogo: N
    pubinfo:
      dt: 4/2/2024
      vid: 21
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        176405915
        176405915
        176405915
        10.1186/s12986-024-00791-2
        176405915
      ppf: 1
      ppct: 17
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Exploration of vitamin D metabolic activity-related biological effects and corresponding therapeutic targets in prostate cancer.
      aug:
        au:
          Ding, Lei
          Wang, Yong
          Tang, Zhentao
          Ni, Chenbo
          Zhang, Qian
          Zhai, Qidi
          Liang, Chao
          Li, Jie
        affil: https://ror.org/04py1g812 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, 210009, Nanjing, China
      sug:
        subj:
          Prostatic Neoplasms Prognosis
          Prostatic Neoplasms Drug Therapy
          Hormone Therapy Methods
          Vitamin D Blood
          Metabolites
          Vitamin D Metabolism
          Signal Transduction
          Prostatic Neoplasms Metabolism
          Tumor Markers, Biological Metabolism
          Genomics
          Human
          Male
          Female
          Funding Source
          Cancer Patients
          Cell Physiology
          Receptors, Cell Surface
          Gene Expression Profiling
          Regression
          Immune System
          Mutation
          Apolipoproteins Blood
          Biochemical Phenomena
          Proteins
          Male
          Female
      ab: Background: Previous studies have unequivocally demonstrated that the vitamin D (VD) metabolism pathway significantly influences prognosis and sensitivity to hormone therapy in prostate cancer (PCa). However, the precise underlying mechanism remains unclear. Methods: We performed molecular profiling of 1045 PCa patients, leveraging genes linked to VD synthesis and VD receptors. We then identified highly variable gene modules with substantial associations with patient stratification. Subsequently, we intersected these modules with differentially expressed genes between PCa and adjacent paracancerous tissues. Following a meticulous process involving single-factor regression and LASSO regression to eliminate extraneous variables and construct a prognostic model. Within the high-risk subgroup defined by the calculated risk score, we analyzed their differences in cell infiltration, immune status, mutation landscape, and drug sensitivity. Finally, we selected Apolipoprotein E (APOE), which featured prominently in this model for further experimental exploration to evaluate its potential as a therapeutic target. Results: The prognostic model established in this study had commendable predictive efficacy. We observed diminished infiltration of various T-cell subtypes and reduced expression of co-stimulatory signals from antigen-presenting cells. Mutation analysis revealed that the high-risk cohort harbored a higher frequency of mutations in the TP53 and FOXA genes. Notably, drug sensitivity analysis suggested the heightened responsiveness of high-risk patients to molecular inhibitors targeting the Bcl-2 and MAPK pathways. Finally, our investigation also confirmed that APOE upregulates the proliferative and invasive capacity of PCa cells and concurrently enhances resistance to androgen receptor antagonist therapy. Conclusion: This comprehensive study elucidated the potential mechanisms through which this metabolic pathway orchestrates the biological behavior of PCa and findings hold promise in advancing the development of combination therapies in PCa.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N